Adults with relapsing MS rated the Sensoready pen, an autoinjector used to self-administer Kesimpta, for ease of use and ...
Recipharm’s new modular sterile filling system, specifically tailored for process development, pilot scale and clinical ...
GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant ...
Prefilled Syringes Market The growing existence of detrimental illnesses is driving the market demand. Critical trends involve the acquisition of green materials, advancement of dual chamber syringes, ...
Copyright 2025 The Associated Press. All Rights Reserved. The Associated Press’ Thomas Adamson talks about the Paris Fashion Week collaboration between Pharrell ...
Polaris Market Research's latest report, titled "Prefilled Syringes Market ,” 2025-2034. The report covers key success factors, market performance, risk factors, project costs and economics ...
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...
The ketamine-derived drug was first approved in 2019 to be used in combination with antidepressants, and later for patients experiencing suicidal thoughts or actions. “Now that it is also ...
This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...
Spravato, which is derived from ketamine, is not a new drug—it first came on the market in 2019. The spray was previously approved as a companion treatment to an oral antidepressant, as well as ...
Following the announcement of the Galaxy S25 series, we've gathered together the latest Samsung Galaxy S25 preorder deals for you to browse right here. If you pre-order a phone in the Samsung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results